# SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study

> **NCT05492227** · — · COMPLETED · sponsor: **TransGen Biotech Co., LTD** · enrollment: 607 (actual)

## Conditions studied

- COVID-19
- Coronavirus Disease 2019
- COVID-19 Pandemic
- Diagnoses Disease

## Interventions

- **DIAGNOSTIC_TEST:** Left-overs

## Key facts

- **NCT ID:** NCT05492227
- **Lead sponsor:** TransGen Biotech Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-05
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05492227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05492227, "SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05492227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*